Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

MMP9 Gene, Metaphyseal Anadysplasia Type 2, Genetic Test in UAE | 2800 AED

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-accredited NGS processing.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731

Test Overview & Methodology

The MMP9 gene sequencing test identifies pathogenic mutations responsible for Metaphyseal Anadysplasia Type 2, a rare autosomal recessive skeletal dysplasia. Our DHA-compliant NGS analysis delivers high-resolution variant detection essential for early pediatric diagnosis, genetic counselling, and personalised management plans.

Feature Our Test (NGS) Closest Alternative (Sanger)
Precision High-depth NGS; detects single nucleotide variants, indels, and copy number changes Limited to point mutations; may miss large deletions/duplications
Method Next-Generation Sequencing (LCโ€‘MS/MS validated bioinformatics) Sanger sequencing of individual exons
Turnaround Time 3 to 4 Weeks 6 to 8 Weeks

Physician Insight & Safety Protocols

โ€œMetaphyseal anadysplasia type 2 requires precise genetic confirmation to guide orthopedic surveillance and family planning. This NGS-based test provides the detail needed for personalized care. Always correlate results with clinical and radiological findings.โ€

โ€” Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)

Critical Advisory

Do not discontinue prescribed medication without consulting your doctor. This test does not replace clinical evaluation.

Exclusion Criteria

  • Recent allogeneic blood transfusion (within 4 weeks) or hematopoietic stem cell transplant.
  • Active systemic infection or febrile illness requiring urgent intervention.

Emergency Red Flags

  • Acute severe limb pain, swelling, or refusal to bear weight โ€” may indicate pathological fracture.
  • Signs of osteomyelitis (fever, localised heat, erythema).
  • Rapid progression of deformity with neurological symptoms.

If any of these signs are present, seek immediate medical attention. This test is elective and not intended for acute diagnostics.

Patient FAQ & Clinical Guidance

1. What sample is required for the MMP9 gene test?

A simple peripheral whole blood sample (2-5 mL) is collected via standard venipuncture. Alternatively, extracted DNA or a dried blood spot on an FTA card is accepted. The sample is transported in a temperature-controlled cold-chain kit to our ISO-accredited laboratory.

2. How long does it take to get results?

Turnaround time is 3 to 4 weeks from sample receipt. This includes library preparation, high-depth NGS sequencing, bioinformatics analysis, and clinical variant interpretation. A detailed English report with DHA attestation is provided.

3. Is genetic counselling mandatory before testing?

Yes, pre-test genetic counselling is required to construct a pedigree, discuss inheritance patterns, and obtain informed consent. This session also prepares families for possible variants of uncertain significance and facilitates long-term follow-up planning.

UAE Regulatory & Data Privacy Adherence

This test is performed under the regulatory framework of the Dubai Health Authority (DHA). Your data is processed in full compliance with:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
  • Federal Decree-Law No. 4 of 2016 on Medical Liability

Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143

Clinical & Logistical Metadata

Test Name MMP9 Gene, Metaphyseal Anadysplasia Type 2, Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks
Sample Type / Matrix Peripheral Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot
Methodology Used Next-Generation Sequencing (NGS)
ICD-10-CM Code Q78.8, Q78.5
LOINC Code 21655-2
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians